Pfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Haley Yamada and Sony SalzmanPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were "no safety concerns" for vaccinated pregnant participants and their newborns during the trial.
Pfizer, the maker of the vaccine, announced Tuesday that the U.S. Food and Drug Administration has accepted its application for review and will make a decision on whether or not to approve the vaccine by August 2023. Pfizer's protein-based RSV vaccine works by vaccinating a pregnant person, who then passes on some protective antibodies to the infant.A Pfizer logo is seen in this illustration, May 1, 2022.RSV usually causes mild, cold-like symptoms, but can become serious, especially for infants and older adults.
The virus is the most common cause of bronchiolitis and pneumonia in kids under the age of 1 in the U.S., according to the CDC.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
1st RSV vaccine could be approved by August, pending FDA reviewThe FDA will decide whether or not to approve an RSV vaccine designed to protect newborns by August 2023.
Weiterlesen »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Weiterlesen »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Weiterlesen »
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This SummerThe single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
Weiterlesen »
1st RSV vaccine could be approved this summerAfter decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August.
Weiterlesen »
FDA agrees to review Pfizer's RSV vaccine for pregnant individualsThe Food and Drug Administration has accepted an application from Pfizer to review its RSV vaccine for pregnant individuals.
Weiterlesen »